BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 16371159)

  • 1. C/EBPbeta-2 confers EGF-independent growth and disrupts the normal acinar architecture of human mammary epithelial cells.
    Bundy L; Wells S; Sealy L
    Mol Cancer; 2005 Dec; 4():43. PubMed ID: 16371159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and function of CCAAT/enhancer binding proteinbeta (C/EBPbeta) LAP and LIP isoforms in mouse mammary gland, tumors and cultured mammary epithelial cells.
    Dearth LR; Hutt J; Sattler A; Gigliotti A; DeWille J
    J Cell Biochem; 2001; 82(3):357-70. PubMed ID: 11500913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCAAT/enhancer binding protein beta (C/EBPbeta)-2 transforms normal mammary epithelial cells and induces epithelial to mesenchymal transition in culture.
    Bundy LM; Sealy L
    Oncogene; 2003 Feb; 22(6):869-83. PubMed ID: 12584567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal growth factor receptor stimulation activates the RNA binding protein CUG-BP1 and increases expression of C/EBPbeta-LIP in mammary epithelial cells.
    Baldwin BR; Timchenko NA; Zahnow CA
    Mol Cell Biol; 2004 May; 24(9):3682-91. PubMed ID: 15082764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCAAT/enhancer binding protein beta (C/EBPβ) isoform balance as a regulator of epithelial-mesenchymal transition in mouse mammary epithelial cells.
    Miura Y; Hagiwara N; Radisky DC; Hirai Y
    Exp Cell Res; 2014 Sep; 327(1):146-55. PubMed ID: 24881817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A role for CCAAT/enhancer binding protein beta-liver-enriched inhibitory protein in mammary epithelial cell proliferation.
    Zahnow CA; Cardiff RD; Laucirica R; Medina D; Rosen JM
    Cancer Res; 2001 Jan; 61(1):261-9. PubMed ID: 11196172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LIP expression is regulated by IGF-1R signaling and participates in suppression of anoikis.
    Li H; Baldwin BR; Zahnow CA
    Mol Cancer; 2011 Aug; 10():100. PubMed ID: 21854628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic profiling of C/EBPβ2 transformed mammary epithelial cells: a role for nuclear interleukin-1β.
    Russell A; Boone B; Jiang A; Sealy L
    Cancer Biol Ther; 2010 Sep; 10(5):509-19. PubMed ID: 21057224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-155-mediated loss of C/EBPβ shifts the TGF-β response from growth inhibition to epithelial-mesenchymal transition, invasion and metastasis in breast cancer.
    Johansson J; Berg T; Kurzejamska E; Pang MF; Tabor V; Jansson M; Roswall P; Pietras K; Sund M; Religa P; Fuxe J
    Oncogene; 2013 Dec; 32(50):5614-24. PubMed ID: 23955085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stabilization of C/EBPβ through direct interaction with STAT3 in H-Ras transformed human mammary epithelial cells.
    Lee LL; Kim SJ; Hahn YI; Jang JH; Saeidi S; Surh YJ
    Biochem Biophys Res Commun; 2021 Mar; 546():130-137. PubMed ID: 33582555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclin D1 and C/EBPβ LAP1 operate in a common pathway to promote mammary epithelial cell differentiation.
    Liu Q; Boudot A; Ni J; Hennessey T; Beauparlant SL; Rajabi HN; Zahnow C; Ewen ME
    Mol Cell Biol; 2014 Aug; 34(16):3168-79. PubMed ID: 24912680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell cycle defects contribute to a block in hormone-induced mammary gland proliferation in CCAAT/enhancer-binding protein (C/EBPbeta)-null mice.
    Grimm SL; Contreras A; Barcellos-Hoff MH; Rosen JM
    J Biol Chem; 2005 Oct; 280(43):36301-9. PubMed ID: 16120603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysophosphatidic acid-induced transactivation of epidermal growth factor receptor regulates cyclo-oxygenase-2 expression and prostaglandin E(2) release via C/EBPbeta in human bronchial epithelial cells.
    He D; Natarajan V; Stern R; Gorshkova IA; Solway J; Spannhake EW; Zhao Y
    Biochem J; 2008 May; 412(1):153-62. PubMed ID: 18294142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. c-erbB2-induced epithelial-mesenchymal transition in mammary epithelial cells is suppressed by cell-cell contact and initiated prior to E-cadherin downregulation.
    Jenndahl LE; Isakson P; Baeckström D
    Int J Oncol; 2005 Aug; 27(2):439-48. PubMed ID: 16010426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EGF-receptor phosphorylation and downstream signaling are activated by benzo[a]pyrene 3,6-quinone and benzo[a]pyrene 1,6-quinone in human mammary epithelial cells.
    Rodríguez-Fragoso L; Melendez K; Hudson LG; Lauer FT; Burchiel SW
    Toxicol Appl Pharmacol; 2009 Mar; 235(3):321-8. PubMed ID: 19166869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EGF-induced C/EBPβ participates in EMT by decreasing the expression of miR-203 in esophageal squamous cell carcinoma cells.
    Li J; Shan F; Xiong G; Chen X; Guan X; Wang JM; Wang WL; Xu X; Bai Y
    J Cell Sci; 2014 Sep; 127(Pt 17):3735-44. PubMed ID: 24994936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGF-β Induced CTGF Expression in Human Lung Epithelial Cells through ERK, ADAM17, RSK1, and C/EBPβ Pathways.
    Ou SC; Bai KJ; Cheng WH; Chen JY; Lin CH; Wen HC; Chen BC
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33260349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LOXL2 induces aberrant acinar morphogenesis via ErbB2 signaling.
    Chang J; Nicolau MM; Cox TR; Wetterskog D; Martens JW; Barker HE; Erler JT
    Breast Cancer Res; 2013; 15(4):R67. PubMed ID: 23971878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multipathway model enables prediction of kinase inhibitor cross-talk effects on migration of Her2-overexpressing mammary epithelial cells.
    Kumar N; Afeyan R; Kim HD; Lauffenburger DA
    Mol Pharmacol; 2008 Jun; 73(6):1668-78. PubMed ID: 18349105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of steroid and prolactin receptor patterning in the mammary gland correlates with a block in lobuloalveolar development.
    Grimm SL; Seagroves TN; Kabotyanski EB; Hovey RC; Vonderhaar BK; Lydon JP; Miyoshi K; Hennighausen L; Ormandy CJ; Lee AV; Stull MA; Wood TL; Rosen JM
    Mol Endocrinol; 2002 Dec; 16(12):2675-91. PubMed ID: 12456789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.